ArticleMediators of inflammation2015

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.

Ho-Chang Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.